FDA Push for Autism-Related Drug Sparks Hype Despite Weak Evidence
The FDA’s promotion of Leucovorin—a decades-old generic medicine—as a potential treatment for certain autism-like symptoms is sparking strong public interest. Parents of autistic children have flooded clinics seeking the drug after it was tied to a rare condition called Cerebral folate deficiency (CFD). Yet medical experts caution that the evidence to support its use in…
